By paul.brackley@iliffemedia.co.uk (Paul Brackley) Dr Harren Jhoti, CEO and co-founder of Cambridge Science Park-based Astex Pharmaceuticals, has been made an OBE after pioneering an approach that changed drug discovery. He has been honoured in the King’s New Year Honours 2023 for services to cancer research and drug discovery. Dr Jhoti co-founded the company in 1999 to pioneer the development of an approach known as fragment-based drug discovery (FBDD), which has now become well established across the pharmaceutical industry. It was used by Astex to help discover two medicines, Kisqali and Ba…
